Is There a Risk of Human Immunodeficiency Virus (HIV) Transmission in Dialysis Centres?

Chirgwin K Rao TKS Landesman SH. HIV infection in a high prevalence haemodialysis unit. AIDS 1989;3:731–5.

Hasan MA Fahmy MY. High HIV seroprevalence in patients with chronic renal failure. VII International Conference on AIDS, June 1991. Abstr MB 2389.

Tokars JI Alter MJ Favero MS Moyer LA Bland LA. National surveillance of haemodialysis associated diseases in the United States: 1990. ASAIO J 1993;39(1):71–80.

Petrosillo N Puro V Ippolito G. Prevalence of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus among dialysis patients. Nephron 1993;64:636–9.

Viguier E Cassuto Dussol B Barrillon D Lerda D Saingra S Cassuto JP. Prevalence of HIV among patients undergoing long-term haemodialysis. IX International Conference on AIDS, June 1993. Abstr PO C21 3137.

Perez G Ortiz-Interian C Bourgoignie JJ HIV-1 and HTLV-1 infection in renal transplant recipients. J Acquir Immune Defic Syndr 1990;3:35–40.

Favero MS Alter MJ. Changing trends in the dialysis of HIV-infected patients in the United States. 1985–1989. VII International Conference on AIDS, June 1991. Abstr MC 3325.

Bourgoignie JJ. Renal complications of human immunodeficiency virus type-1. Kidney Int 1990;37:1571–84.

Ippolito G Petrosillo N Puro V Arici C. HIV prevalence in dialysis patients in Italy. The Italian group on blood borne infections in dialysis. VIII International Conference on AIDS, July 1992. Abstr PoC 4670.

Stevens A Little J Kerr S Kilbane P Doherty C. HIV testing in patients with end stage renal disease. BMJ 1990;300:447–9.

Scherting DG Butera E. Haemodialysis of HIV-positive patients: Impact on organisation and staff. ANNA J 1990;17(1):13–18 and 28.

Marcus R Favero MS Banerjee S Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term haemodialysis. Am J Med 1991;90(5):614–19.

Special report: American Kidney Fund sponsors AIDS consensus conference. Washington DC; American Kidney Fund 1988, pp 1–2.

Department of Health and Social Security, Scottish Home and Health Department, Welsh Office. Hepatitis and the treatment of chronic renal failure. Report of the Advisory Group 1970–72. London: HMSO, 1972.

Anonymous. Hepatitis in dialysis units. BMJ 1970;4:255–6.

Anonymous. Hepatitis hazard in regular haemodialysis. BMJ 1972;4:501–2.

Brock JS Sussman M Wamsley M Mintzer R Baumann G Riles TS. The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vase Surg 1992;16:904–12.

Rubin RH Tolkoff-Rubin NE. The problem of human immunodeficiency (HIV) infection and transplantation. Transpl Int 1988;1:36–42.

Glassock RJ Cohen AH Danovitch G Parsa KP. Human Immunodeficiency Virus (HIV) Infection and the kidney. Ann Intern Med 1990;112:35–49.

Arnow PM Fellner S Harrington R Leuther M. False-positive results of screening for antibodies to human immunodeficiency virus in chronic haemodialysis patients. Am J Kidney Dis 1988;11:383–6.

Baltimore-Boston Collaborative study group. Human immunodeficiency virus infection in haemodialysis patients. Arch Intern Med 1988;148:617–9.

Nurith V Yusy I Ami V Yarkobovskia E Burke M. ELISA positive indeterminate western blot results in haemodialysis patients. IX International Conference on AIDS, June 1993. Abstr PO B40 2416.

Peterman TA Lang GR Mikos NJ HTLV-III/LAV infection in haemodialysis patients. JAMA 1986;255(17):2324–6.

Johnston BL Poole CL Zito DR Normansell DE Westervelt FB Jr Farr BM. Cohort study of human immunodeficiency virus (HIV) antibody testing among patients receiving long-term dialysis at a university hospital. Am J Infect Control 1988;16(6):235–40.

Kuhnl P Seidl S Holzberger G. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results (Letter), lancet 1985;i:1222–3.

Humphreys MH Schoenfeld PY. AIDS and renal disease. The Kidney 1987;20:7–12.

Rao TKS Friedman EA Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987;316:1062–8.

Bourgoignie JJ Meneses R Ortiz C Jaffe D Pardo V. The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 1988;12:131–7.

Marcus R Solomon S Favero M Martone W. Human immunodeficiency virus (HIV) antibody in patients undergoing chronic haemodialysis. Kidney Int 1989;35:255.

Assogba U Rey MA Ancelle RM Rottembourg J Gluckman JC. HIV-1 infection in dialysis centres. Prospective studies in 4 centres in Ile-de-France. Nephrologie 1988;9(3):139–41.

Perez GO Ortiz C De-Medina M Schiff E Bourgoignie JJ. Lack of transmission of human immunodeficiency virus in chronic haemodialysis patients. Am J Nephrol 1988;8(2):123–6.

Perez-Garcia R Luno J Lopez-Gomez JM Franco A Valderrabano F Gurbindo-Gutierrez MD. Outcome of patients with human immunodeficiency virus (HIV) on chronic dialysis. V International Conference on AIDS, June 1989. Abstr MBP 277.

Bobji B. AIDS risk in plasma exchange and dialysis. VI International Conference of AIDS, June 1990. Abstr 3184.

Salmao R Accetturi C Barata R Salvador J Longo IM Mendes NF. Case control study in HIV seropositivity in haemodialysis patients. V International Conference on AIDS, June 1989 Abstr TBP 356.

Fassbinder W Kuhnl P Neumayer HH Offermann G Seidl S Schoeppe W. Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with haemodialysis and following renal transplantation. Dtsch Med Wochenschr 1986;111(28–29):1087–90.

Perez G Ortiz-Interian C Lee H Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance haemodialysis in Miami. Am J Kidney Dis 1989;14(1):39–43.

Teixido‘ J Argelague's E Caralps A Anti-HTLV-III antibodies in dialysed or transplanted patients in Spain [letter]. Nephron 1987;46:325–6.

Centers for Disease Control: Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy associated virus. MMWR 1986;35:376–83.

Rubin J. Prevalence of HIV virus among patients undergoing continuous ambulatory peritoneal dialysis. ASAIO Trans 1989;35(2):144–5.

Boucher CA de-Gans J Van-Oers R Danner S Goudsmit J. Transmission of HIV and AIDS by plasmapheresis for Guillain-Barré Syndrome. Clin Neurol Neurosurg 1988;90(3):235–6.

VedBrar SS Kimmel PL Pierce PF Shepherd L Hellman KB. Plasma viraemia in HIV seropositive dialysis vs non-dialysis patients. VIII International Conference on AIDS, July 1992. Abstr PoB 3820.

Berlyne G Kaczmarek RG Hamburger S Seroprevalence of antibodies to the human immunodeficiency virus in dialysis workers: Results of multicenter study. Nephron 1992;62(4):441–3.

Ortiz C Meneses R Jaffe D Outcome of patients with human immunodeficiency virus on maintenance haemodialysis. Kidney Int 1988;34:248–53.

Correa-Rotter R Saldivar S Soto LE De Leon F Ponce Ruiz-Palacios G Pena JC. Recovery of HIV antigen in peritoneal dialysis fluid. Perit Dial Int 1990;10(1):67–9.

Williams PF Swan B Cunningham K. Continuous ambulatory peritoneal dialysis fluid: Another fluid positive for HIV antibody? BMJ 1986;293:885.

Breyer JA Harbison MA. Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 1993;21(1):23–5.

Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(2S):1S–18S.